United States· US:71205-068_0073dfe4-2772-4fc6-a391-504cd2c4a8fb
Methocarbamol
A methocarbamol product containing methocarbamol, registered in United States by Proficient Rx LP. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Methocarbamol is registered in 12 of 19 countries.
Countries holding a registration under ATC M03BA03 (methocarbamol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Methocarbamol · ATC M03BA03
12 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methocarbamol costs, country by country.
Normalised to the WHO defined daily dose (3 g), so markets compare like for like.
- United States: $0.17 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Methocarbamol · price per daily dose (3 g)
USD · FX 28 Sept 2026
- US United States$0.17 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHOCARBAMOL
- Manufacturer
- Proficient Rx LP
- Country
- United States (US)
- ATC code
- M03BA03
- ATC class
- Methocarbamol
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 12
- ndc11712050682020 TABLET, COATED in 1 BOTTLE (71205-068-20)
- ndc11712050683030 TABLET, COATED in 1 BOTTLE (71205-068-30)
- ndc11712050684040 TABLET, COATED in 1 BOTTLE (71205-068-40)
- ndc11712050684545 TABLET, COATED in 1 BOTTLE (71205-068-45)
- ndc11712050686060 TABLET, COATED in 1 BOTTLE (71205-068-60)
- ndc11712050689090 TABLET, COATED in 1 BOTTLE (71205-068-90)
- ndc1171205-068-90
- ndc1171205-068-20
- ndc1171205-068-30
- ndc1171205-068-40
- ndc1171205-068-45
- ndc1171205-068-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
169 interactions on record for methocarbamol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methocarbamol · interactions on record
169 records
- 4 severe
- 53 moderate
- 112 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methocarbamol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMethocarbamol 1500mg tabletsA A H Pharmaceuticals Ltd
- GermanyMethocaPuren Pharma Gmbh & Co. Kg
- CzechiaDOLIROBAXGOODWILL PHARMA Plc., Szeged
- SpainDOLIROBAX 500 MG COMPRIMIDOSFaes Farma S.A.
- SwitzerlandMetoflex 750 mg, comprimésLabatec Pharma SA
- FranceLUMIRELAX 10 %, crèmeLABORATOIRES JUVISE PHARMACEUTICALS
- NorwayMethocarbamol alAliud Pharma
- CanadaROBAXIN 750HALEON CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Methocarbamol Kwizda
- Czechia · Dolirobax
- Germany · Methoca, Methocarbamol Al
- Spain · Dolirobax, Molitrem
- France · Lumirelax, Methocarbamol Arrow
- United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
- Hungary · Dolirobax Tabletta
- Luxembourg · Methocarbamol Micro Labs
- Malta · Rolaxifor
- Poland · Methocarbamol Espefa
- Portugal · Robaxisal, Zelaz
- Slovakia · Dolirobax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e667e088-cc6e-4963-a97c-c9f2575d3275 GET /v1/drugs/e667e088-cc6e-4963-a97c-c9f2575d3275?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "750",
"substance": "METHOCARBAMOL",
"productndc": "71205-068",
"dosage_form": "TABLET, COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA209312",
"marketing_category": "ANDA"
}See everything about methocarbamol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.